Gleason Group, Inc.

Position in INCY — Incyte Corp

CIK 1822632 PROSPECT, KY

Position in INCY

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$7,623

-$377 QoQ

Shares Held

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Gleason Group, Inc. holds $107,980 across 6 Biotechnology names. INCY ranks #4 (7.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ACTU	Actuate Therapeutics, Inc.	19,028	$52,136
2	RNTX	Rein Therapeutics, Inc.	22,389	$29,105
3	MDXG	Mimedx Group, Inc.	2,712	$10,712
4	INCY	Incyte Corp This page	81	$7,623
5	APTOF	Aptose Biosciences Inc.	4,206	$7,024
6	CUE	Cue Biopharma, Inc.	6,000	$1,380

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,623	81	0.0%	Shares	Sole	2026-05-04
2025-12-31	$8,000	81	—	Shares	Sole	2026-01-15
No filing history on record for this holder in this stock.